Cavallo G P, Giordano C
Cattedra di Clinica Otorinolaringoiatrica, Università di Torino.
G Batteriol Virol Immunol. 1988 Jan-Dec;81(1-12):47-53.
Continuing development of antimicrobial resistance highlights the need for new antimicrobial agents. Despite many new molecules there is still a need for effective oral compounds. The fluoroquinolones are a new group of antibiotics with a wide spectrum of antibacterial activity which includes resistant strains and difficult microorganisms as Pseudomonas aeruginosa. Ofloxacin is a fluoroquinolone available for oral use showing good absorption with high blood levels and quite satisfactory tissue, penetration particularly in O.R.L. district. The treatment, consisting of ofloxacin 200 mg twice daily, of several patient (including two cases of rhinitis) was both safe and effective.
抗菌药物耐药性的持续发展凸显了新型抗菌药物的必要性。尽管有许多新的分子,但仍需要有效的口服化合物。氟喹诺酮类是一类新型抗生素,具有广泛的抗菌活性,包括耐药菌株和如铜绿假单胞菌等难对付的微生物。氧氟沙星是一种可供口服的氟喹诺酮类药物,吸收良好,血药浓度高,组织穿透力相当令人满意,尤其是在耳鼻喉区域。对几名患者(包括两例鼻炎患者)采用每日两次200毫克氧氟沙星进行治疗,既安全又有效。